Hormonal Contraceptives Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to hormonal contraceptives market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Hormonal Contraceptives Market News

in Hormonal Contraceptives Market
  • In March 2025, NEXT Life Sciences, the modern reproductive healthcare company, announced the announced the beginning of Male contraceptive clinical trial in Australia. This launch of Plan A clinical trail takes the NEXT life science contraceptive solution from pre-clinical stage to clinical stage.  The initiation of clinical trials in Australia represents a significant advancement in male contraceptive development.
  • In August 2024, Perrigo Company Plc., one of the leading provider of Consumer self-product company, announced that Opill, a birth control pill partner with Women’s National Basketball Association (WNBA). The partnership focus on building strength, health equity and confidence
  • In January 2025, Lupin, a pharmaceutical company, announced the launch of Minozoya in various dosage in United States. This product also receive approval from the US FDA. This product is used by females in order to prevent pregnancy.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Hormonal Contraceptives Market size was valued at USD 17.1 Billion in 2023 and is poised to grow from USD 17.8 Billion in 2024 to USD 25.0 Billion by 2032, growing at a CAGR of 4.3% in the forecast period (2025-2032).

To remain competitive in the Hormonal Contraceptives Market, major manufacturers focus on regulatory compliance, product innovation, and expanding access through partnership. The key payers invest in research & development in order to develop advanced formulations such as long-acting injectables which increase production processes to meet the regulatory standard. Acquisition and mergers also drive the market expansion. With the increasing demand for non-oral options among consumers, various companies are diversifying their product portfolio and enhancing their sustainability efforts. 'AbbVie', 'Bayer', 'Pfizer Inc.', 'Merck & Co., Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V. (Viatris Inc.)', 'Allergan plc', 'Johnson & Johnson', 'Agile Therapeutics', 'Organon Group', 'Afaxys, Inc.', 'HRA Pharma', 'Piramal Enterprises Ltd.', 'Novartis AG', 'GlaxoSmithKline plc', 'Dr. Reddy's Laboratories Ltd.', 'Cupid Limited', 'Lupin Pharmaceuticals, Inc.', 'Theramex', 'Evotec SE', ''

The increase in awareness about family planning, coupled with rising female education levels are one of the key factors for the growth of the market. The Family Planning 2030 (FP2030) aims to enable nearly 120 million women and girls to access modern contraceptive in middle- and low-income countries. As of 2023, nearly 370 million women were using modern contraceptive, with hormonal methods, such as injectables and orals pills, globally.

Short-Term: The rapid digital transformation in contraceptive industry with the launch of various app-based prescription services and telemedicine is making hormonal contraceptive user friendly. The increasing demand for convenience and privacy mostly among millennial and Gen Z, the healthcare providers are adopting digital platforms for prescription management, compliance tracking and improve consultancy. These developments are increasing the adherence rate and user satisfaction.

Why is Asia Pacific Leading Hormonal Contraceptives Market in 2024?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Hormonal Contraceptives Market
Hormonal Contraceptives Market

Report ID: SQMIG35I2363

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE